QCOR Dividend History & Description — Questcor Pharmaceuticals Inc
Questcor Pharmaceuticals is a pharmaceutical company. Co.'s primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug used for the treatment of exacerbations of multiple sclerosis in adults, proteinuria in the nephrotic syndrome of the idiopathic type, and infantile spasms in infants and children. Co. also markets Doral® (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. Co. has registered trademarks on H.P. Acthar® Gel and Doral®.